任丹阳, 刘昶煦, 李玲妹, 黄秋娟, 齐丽莎, 曹文枫. CaMKⅡ高表达通过EMT促进肺腺癌侵袭转移[J]. 中国肿瘤临床, 2022, 49(11): 548-553. DOI: 10.12354/j.issn.1000-8179.2022.20211710
引用本文: 任丹阳, 刘昶煦, 李玲妹, 黄秋娟, 齐丽莎, 曹文枫. CaMKⅡ高表达通过EMT促进肺腺癌侵袭转移[J]. 中国肿瘤临床, 2022, 49(11): 548-553. DOI: 10.12354/j.issn.1000-8179.2022.20211710
shu
Danyang Ren, Changxu Liu, Lingmei Li, Qiujuan Huang, Lisha Qi, Wenfeng Cao. CaMKⅡ high expression through epithelial-mesenchymal transition promotes lung adenocarcinoma invasion and metastasis[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 49(11): 548-553. DOI: 10.12354/j.issn.1000-8179.2022.20211710
Citation: Danyang Ren, Changxu Liu, Lingmei Li, Qiujuan Huang, Lisha Qi, Wenfeng Cao. CaMKⅡ high expression through epithelial-mesenchymal transition promotes lung adenocarcinoma invasion and metastasis[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 49(11): 548-553. DOI: 10.12354/j.issn.1000-8179.2022.20211710
shu

CaMKⅡ高表达通过EMT促进肺腺癌侵袭转移

CaMKⅡ high expression through epithelial-mesenchymal transition promotes lung adenocarcinoma invasion and metastasis

    摘要
  • 摘要:
      目的  探究钙/钙调蛋白依赖性蛋白激酶Ⅱ（calcium/calmodulin-dependent protein kinase Ⅱ，CaMKⅡ）在肺腺癌组织中的表达及其促进肺腺癌的侵袭、转移。
      方法  通过免疫组织化学染色（immunohistochemistry，IHC）分析肺腺癌患者的石蜡组织标本CaMKⅡ表达与临床病理参数关系，同时对肺腺癌组织与其配对淋巴结转移病灶中的CaMKⅡ表达情况进行比较分析，收集2011年1月至2011年12月于天津医科大学肿瘤医院行手术治疗的113例肺腺癌患者及21例配对的原发病灶及淋巴结转移病灶的石蜡组织标本。将肺腺癌细胞系H1299及Calu3进行慢病毒转染，实验组转染高表达CaMKⅡ病毒，对照组转染阴性对照病毒，通过Transwell实验和划痕实验检测肺腺癌细胞侵袭、转移能力，通过Western blot 检测CaMKⅡ表达水平与上皮间充质转化（pithelial-mesenchymal transition，EMT）相关指标和表皮生长因子受体（epidermal growth factor receptor，EGFR）通路激活间的关系。
      结果  CaMKⅡ高表达与肺腺癌TNM分期和淋巴结转移呈正相关，肺腺癌淋巴结转移病灶中的癌组织CaMKⅡ表达明显高于其原发病灶（P<0.05）。细胞实验表明，CaMKⅡ高表达的肺腺癌细胞，其穿膜细胞数目明显增多，伤口愈合能力增强； EGFR通路激活后p-CaMKⅡ水平增加，且CaMKⅡ促进了EMT相关蛋白及转录因子的表达。
      结论  CaMKⅡ参与EGFR信号传导，促进EMT过程，增加肺腺癌的侵袭转移能力。

     

    Abstract:
      Objective  To investigate the expression of calcium/calmodulin-dependent protein kinase II (CaMKⅡ) in lung adenocarcinoma and determine its role in lung adenocarcinoma invasion and metastasis.
      Methods  The relationship between the expression of CaMKⅡ and clinicopathological parameters of patients with lung adenocarcinoma was analyzed using immunohistochemistry (IHC) staining of paraffin-embedded tissue sections. Concurrently, the expression of CaMKⅡ in lung adenocarcinoma and its paired lymph node metastases was compared, paraffin tissue samples from 113 patients with lung adenocarcinoma and 21 matched primary and lymph node metastases were collected from patients with lung adenocarcinoma who underwent surgical treatment in Tianjin Medical University Cancer Institute & Hospital from January to December 2011. The H1299 and Calu3 lung adenocarcinoma cell lines were transfected lentivirus with the high expression CaMKⅡ vector in the experimental group and negative control vector in the control group. Invasion and metastasis of the lung adenocarcinoma cells were investigated using Transwell and scratch tests, respectively. The relationship between CaMKⅡ expression and epithelial–mesenchymal transformation (EMT) and the activation of the epidermal growth factor receptor (EGFR) pathway was detected using Western blot.
      Results  Clinicopathological analysis revealed that the expression of CaMKⅡ was positively correlated with TNM stage and lymph node metastasis of lung adenocarcinoma. The expression of CaMKⅡ in lung adenocarcinoma with lymph node metastasis was significantly higher than that in the primary tumor (P<0.05). In vitro experiments showed that the number of transmembrane lung adenocarcinoma cells with increased CaMKⅡ expression was significantly elevated and the wound healing ability was enhanced. The level of phosphorylated-CaMKⅡ increased after the activation of the EGFR pathway, and CaMKⅡ promoted the expression of EMT-related proteins and transcription factors.
      Conclusions  CaMKⅡ participates in EGFR signal transduction, promotes the EMT process, and increases the invasion and metastasis abilities of lung adenocarcinoma cells.

     

    • HTML全文
    • 参考文献(23)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回